Report Detail

Pharmaceuticals & Healthcare Partnerships, Licensing, Investments and M&A Deals and Trends for June 2019 in Pharmaceuticals

  • RnM3811672
  • |
  • 10 October, 2019
  • |
  • Global
  • |
  • 85 Pages
  • |
  • GlobalData
  • |
  • Pharmaceuticals & Healthcare

1 Table of Contents

    2 Pharmaceuticals & Healthcare, Global, Deal Summary

    • 2.1 Pharmaceuticals & Healthcare, Global, Deal Analysis, June 2019
    • 2.2 Pharmaceuticals & Healthcare, Global, Major Deals, June 2019
      • 2.2.1 AbbVie to Acquire Allergan
      • 2.2.2 Pfizer to Acquire Array BioPharma
      • 2.2.3 Dassault Systemes to Acquire Medidata Solutions for USD5.8 Billion
      • 2.2.4 Medtronic Raises USD4.5 Billion in public offering of Notes
      • 2.2.5 Gilead Sciences and Nurix Terapeutics Enter into Agreement
    • 2.3 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, June 2019
    • 2.4 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, June 2019

    3 Pharmaceuticals and Healthcare, Global, Deals, Summary, by Type

    • 3.1 Pharmaceuticals & Healthcare, Global, M&A, June 2019
      • 3.1.1 Top M&A Deals in June 2019
      • 3.1.2 Pharmaceuticals & Healthcare, Global, M&A Deals by Therapy Area, January 2019 - June 2019
    • 3.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, June 2019
      • 3.2.1 Top Equity Offering Deals in June 2019
      • 3.2.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals by Therapy Area, January 2019 - June 2019
    • 3.3 Pharmaceuticals & Healthcare, Global, Private Equity and Venture Capital Deals, June 2019
      • 3.3.1 Top PE/VC Deals in June 2019
      • 3.3.2 Pharmaceuticals & Healthcare, Global, PE/VC by Therapy Area, June 2019
      • 3.3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, June 2019
      • 3.3.5 Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, June 2016-June 2019
      • 3.3.7 Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, June 2016-June 2019
    • 3.4 Pharmaceuticals & Healthcare, Global, Partnership Deals, June 2019
    • 3.5 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, January 2019 - June 2019
    • 3.6 Pharmaceuticals & Healthcare, Global, Partnership Deals by Upfront and Milestone Payments and Deal Values (US$ m), June 2019
      • 3.6.1 Pharmaceuticals & Healthcare, Global, Top Partnership Deals by Payment Mode, June 2019
    • 3.7 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, by Upfront and Milestone Payments and Deal Values (US$ m), January 2019 - June 2019
    • 3.8 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Number Of Deals, January 2019 - June 2019
    • 3.9 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Deal Values (US$ m), January 2019 - June 2019
    • 3.10 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), January 2019 - June 2019

    4 Pharmaceuticals & Healthcare, Global, Licensing Agreements, June 2019

    • 4.1 Pharmaceuticals & Healthcare, Global, Licensing Agreements, June 2019
    • 4.2 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront and Milestone Payments and Deal Values (US$ m), June 2019
    • 4.3 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Total Deal Values (US$ m), January 2019 - June 2019
    • 4.4 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Upfront Payments and Milestone Payments (US$ m), January 2019 - June 2019
    • 4.5 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Total Deal Values (US$ m), January 2019 - June 2019
    • 4.6 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Upfront Payments and Milestone Payments (US$ m), January 2019 - June 2019
      • 4.6.1 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Deal Value, June 2019
      • 4.6.2 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Upfront Payments, June 2019
      • 4.6.3 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Total Milestone Payment, June 2019

    5 Pharmaceuticals & Healthcare, Global, Deal Summary by Therapy Area

    • 5.1 Pharmaceuticals & Healthcare, Global, Oncology Deals, June 2019
      • 5.1.1 Oncology - Deals of the Month
    • 5.2 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, June 2019
      • 5.2.1 Central Nervous System - Deals of the Month
    • 5.3 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, June 2019
      • 5.3.1 Infectious Diseases - Deals of the Month
    • 5.4 Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, June 2019
      • 5.4.1 Cardiovascular - Deals of the Month
    • 5.5 Pharmaceuticals & Healthcare, Global, Immunology Deals, June 2019
      • 5.5.1 Immunology - Deal of the Month
    • 5.6 Pharmaceuticals & Healthcare, Global, Gastrointestinal Deals, June 2019
      • 5.6.1 Gastrointestinal - Deals of the Month
    • 5.7 Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Deals, June 2019
      • 5.7.1 Metabolic Disorders - Deals of the Month

    6 Deal Summary by Geography

    • 6.1 Pharmaceuticals & Healthcare, North America Deals, June 2019
      • 6.1.1 North America - Deals of the Month
    • 6.2 Pharmaceuticals & Healthcare, Europe, Deals, June 2019
      • 6.2.1 Europe - Deals of the Month
    • 6.3 Pharmaceuticals & Healthcare, Asia-Pacific, Regional Deals, June 2019
      • 6.3.1 Asia-Pacific - Deals of the Month
    • 6.4 Pharmaceuticals & Healthcare, Rest of the World, Deals, June 2019
      • 6.4.1 Rest of the World - Deals of the Month

    7 Pharmaceuticals & Healthcare, Global, Top Financial Advisors

    • 7.1 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, M&A, January 2019 - June 2019
    • 7.2 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, January 2019 - June 2019

    8 Further Information

    • 8.1 Methodology
    • 8.2 About GlobalData
    • 8.3 Contact Us
    • 8.4 Disclosure information

    Partnerships, Licensing, Investments and M&A Deals and Trends for June 2019 in Pharmaceuticals

    Summary

    GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends for June 2019 in Pharmaceuticals” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in June 2019. The report portrays detailed comparative data on the number of deals and their value in the last six months, subdivided by deal types, various therapy areas, and geographies. Additionally, the report provides information on the top financial advisory firms in the pharmaceuticals industry.

    Data presented in this report is derived from GlobalData’s proprietary in-house Pharmaceuticals eTrack deals database and primary and secondary research.

    Scope

    - Analysis of the market trends for the pharmaceutical industry in the global arena.
    - Review of deal trends in the cardiovascular, central nervous system, dermatology, ear nose throat disorders, gastrointestinal, genito urinary system and sex hormones, hematological disorders, hormonal disorders, immunology, infectious disease, male health, metabolic disorders, mouth and dental disorders, musculoskeletal, oncology, ophthalmology, respiratory, toxicology, and women's health segments.
    - Analysis of partnerships, licensing, M&As, equity/debt offerings, private equity, and venture financing deals in the pharmaceutical industry.
    - Analysis of therapy areas which are very active in terms of venture capital financing, partnerships, licensing agreements, equity/debt offerings, and M&As.
    - Analysis of deals based on different payment modes, including upfront and milestone payments, primarily in partnerships and licensing agreements in the pharmaceutical industry.
    - Analysis of partnership and licensing deals based on clinical stage of development of products.
    - Summary of the pharmaceutical deals globally in the six months.
    - Information on the top deals happened in the pharmaceutical industry.
    - Geographies covered include - North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa.
    - League tables of financial advisors in M&As and equity/debt offerings. This includes key advisors such as Morgan Stanley, Credit Suisse, and Goldman Sachs.

    Reasons to buy

    - Enhance your decision making capability in a more rapid and time sensitive manner.
    - Find out the major deal performing segments for investments in your industry.
    - Evaluate the types of companies which are entering into partnership or licensing agreements; divesting and acquiring assets.
    - Identify companies that are aggressively looking to raise capital in the market
    - Evaluate niche therapy areas that are receiving majority of the upfront and milestone payments in the pharmaceutical industry.
    - Identify the key venture capitalists, who are financing the pharmaceutical and biotech companies.
    - Evaluate the clinical development stages where majority of the partnerships and licensing agreements are happening.
    - Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the pharmaceutical industry.
    - Identify growth segments and opportunities in each region within the industry.
    - Look for key financial advisors where you are planning to raise capital from the market or for acquisitions within the industry.


    Summary:
    Get latest Market Research Reports on Partnerships, Licensing, Investments and M&A Deals. Industry analysis & Market Report on Partnerships, Licensing, Investments and M&A Deals is a syndicated market report, published as Partnerships, Licensing, Investments and M&A Deals and Trends for June 2019 in Pharmaceuticals. It is complete Research Study and Industry Analysis of Partnerships, Licensing, Investments and M&A Deals market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $1,000.00
    $2,000.00
    $3,000.00
    773.06
    1,546.12
    2,319.18
    897.84
    1,795.67
    2,693.51
    108,570.00
    217,140.00
    325,710.00
    70,921.60
    141,843.20
    212,764.80
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report